Publications in collaboration with researchers from Novartis (Sweden) (2)

2013

  1. Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation

    Transplant Infectious Disease, Vol. 15, Núm. 2, pp. 150-162

2010

  1. Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: A randomized, multicenter study

    Transplant Infectious Disease, Vol. 12, Núm. 1, pp. 23-30